open mobile menu
Improvement in biomarkers in patients with ulcerative colitis treated with vedolizumab: Results from the continuing VERDICT trial
Poster SU1941

SESSION INFORMATION
Presenter: Dr. Vipul Jairath
Title: IBD: Disease Activity Assessment and Monitoring
Date & Time: May 4, 2025 | 12:30–1:30 pm PDT

Placebo rates in randomized clinical trials of ulcerative colitis: An individual patient data meta-analysis
Poster SU1834

SESSION INFORMATION
Presenter: Dr. Virginia Solitano
Title: IBD: Controlled Clinical Trials in Humans
Date & Time: May 4, 2025 | 12:30–1:30 pm PDT

Development, internal, and external validation of a novel endoscopic activity score for evaluation of Crohn’s disease
(EASE-CD)
Research Forum 484

SESSION INFORMATION
Presenter: Dr. Christopher Ma
Title: Recent Advances in IBD Monitoring
Date & Time: May 4, 2025 | 2:00–3:30 PM PDT

Target achievement after 48 weeks of vedolizumab treatment in patients with moderate to severe ulcerative colitis: an interim analysis from the VERDICT trial
Research Forum 1114

SESSION INFORMATION
Presenter: Dr. Vipul Jairath
Title: Clinical Trials in IBD: Small Molecules and Monitoring Strategies  
Date & Time: May 6, 2025 | 10:00–11:30 am PDT